scispace - formally typeset
K

Kounosuke Watabe

Researcher at Wake Forest University

Publications -  179
Citations -  11680

Kounosuke Watabe is an academic researcher from Wake Forest University. The author has contributed to research in topics: Cancer & Metastasis. The author has an hindex of 53, co-authored 161 publications receiving 9728 citations. Previous affiliations of Kounosuke Watabe include Wake Forest Baptist Medical Center & Southern Illinois University School of Medicine.

Papers
More filters
Journal ArticleDOI

p53 represses c-Myc through induction of the tumor suppressor miR-145

TL;DR: The role of miR-145 is defined in the posttranscriptional regulation of c-Myc by p53 and it is suggested that, as a new member of the p53 regulatory network, mi R-145 provides a direct link between p 53 and c- myc in this gene regulatory network.
Journal ArticleDOI

Cancer associated fibroblasts (CAFs) in tumor microenvironment.

TL;DR: The latest findings on the role of CAFs in tumorigenesis and metastasis as well as potential therapeutic implication ofCAFs are discussed.
Journal ArticleDOI

Negative regulation of lncRNA GAS5 by miR-21

TL;DR: Results suggest that miR-21 targets not only tumor-suppressive protein-coding genes but also lncRNA GAS5, and may regulate each other in a way similar to the microRNA-mediated silencing of target mRNAs.
Journal ArticleDOI

Fatty Acid Synthase Gene Is Up-regulated by Hypoxia via Activation of Akt and Sterol Regulatory Element Binding Protein-1

TL;DR: The results indicate that FAS gene is up-regulated by hypoxia via activation of the Akt and HIF1 followed by the induction of the SREBP-1 gene, and that Hypoxia-induced chemoresistance is partly due to the up-regulation of FAS.
Journal ArticleDOI

Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone

TL;DR: BMP7 released by bone marrow stromal cells induces reversible senescence of prostate cancer stem-like cells, and BMPR2 expression inversely correlates with bone metastasis and recurrence in prostate cancer patients.